Skip to main content
Premium Trial:

Request an Annual Quote

Clinton Musil

Clinton Musil has been appointed as chief business officer of Personalis, where he will initially focus on financing strategy. He joins the company from ARMO Biosciences. Prior to that, he was a managing director at Hercules Capital. Musil holds an MBA from Harvard Business School and a BS in molecular and cellular biology from the University of Arizona.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.